Correction: β-Agonists selectively modulate proinflammatory gene expression in skeletal muscle cells via non-canonical nuclear crosstalk mechanisms (PLoS ONE (2014) 9:3 (e90649) DOI: 10.1371/journal.pone.0090649);β-agonists selectively modulate proinflammatory gene expression in skeletal muscle cells via non-canonical nuclear crosstalk mechanisms

PLoS ONE

Volumn 9, Issue 3, 2014, Pages

  Kolmus, Krzysztof ^a,b   Van Troys, Marleen ^b   Van Wesemael, Karlien ^c   Ampe, Christophe ^b   Haegeman, Guy ^c   Tavernier, Jan ^a,b   Gerlo, Sarah ^a,b  

^a DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

^b GHENT UNIVERSITY   (Belgium)

^c GHENT UNIVERSITY   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CELL PROTEIN; CHEMOKINE; CHEMOTACTIC FACTOR; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN BINDING PROTEIN; G PROTEIN COUPLED RECEPTOR; HISTONE H3; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; ISOPRENALINE; MITOGEN ACTIVATED PROTEIN KINASE; RNA POLYMERASE II; SERINE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CHROMATIN; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; GENE EXPRESSION; HISTONE PHOSPHORYLATION; IN VITRO STUDY; LUCIFERASE ASSAY; MOUSE; MUSCLE CELL; MYOTUBE; NONHUMAN; PROMOTER REGION; REAL TIME POLYMERASE CHAIN REACTION; SKELETAL MUSCLE; WESTERN BLOTTING;

EID: 84897146882     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0287938     Document Type: Erratum

References (66)

1. Peterson JM, Guttridge DC (2008) Skeletal muscle diseases, inflammation, and NF-kappaB signaling: insights and opportunities for therapeutic intervention. Int Rev Immunol 27: 375-387.
2. Li YP, Reid MB (2001) Effect of tumor necrosis factor-alpha on skeletal muscle metabolism. Curr Opin Rheumatol 13: 483-487.
3. Dempsey PW, Doyle SE, He JQ, Cheng G (2003) The signaling adaptors and pathways activated by TNF superfamily. Cytokine Growth Factor Rev 14: 193-209. (Pubitemid 36693141)
4. Hayden MS, Ghosh S (2012) NF-kappaB, the first quarter-century: remarkable progress and outstanding questions. Genes Dev 26: 203-234.
5. Mourkioti F, Rosenthal N (2008) NF-kappaB signaling in skeletal muscle: prospects for intervention in muscle diseases. J Mol Med (Berl) 86: 747-759.
6. Lynch GS, Ryall JG (2008) Role of beta-adrenoceptor signaling in skeletal muscle: implications for muscle wasting and disease. Physiol Rev 88: 729-767. (Pubitemid 351520091)
7. Beitzel F, Gregorevic P, Ryall JG, Plant DR, Sillence MN, et al. (2004) Beta2-adrenoceptor agonist fenoterol enhances functional repair of regenerating rat skeletal muscle after injury. J Appl Physiol 96: 1385-1392. (Pubitemid 38392675)
8. Ryall JG, Gregorevic P, Plant DR, Sillence MN, Lynch GS (2002) Beta 2-agonist fenoterol has greater effects on contractile function of rat skeletal muscles than clenbuterol. Am J Physiol Regul Integr Comp Physiol 283: R1386-1394. (Pubitemid 35340653)
9. Hinkle RT, Hodge KM, Cody DB, Sheldon RJ, Kobilka BK, et al. (2002) Skeletal muscle hypertrophy and anti-atrophy effects of clenbuterol are mediated by the beta2-adrenergic receptor. Muscle Nerve 25: 729-734. (Pubitemid 34462614)
10. Farmer P, Pugin J (2000) beta-adrenergic agonists exert their "anti-inflammatory" effects in monocytic cells through the IkappaB/NF-kappaB pathway. Am J Physiol Lung Cell Mol Physiol 279: L675-682.
11. Ye RD (2000) beta-Adrenergic agonists regulate NF-kappaB activation through multiple mechanisms. Am J Physiol Lung Cell Mol Physiol 279: L615-617.
12. Gavrilyuk V, Dello Russo C, Heneka MT, Pelligrino D, Weinberg G, et al. (2002) Norepinephrine increases I kappa B alpha expression in astrocytes. J Biol Chem 277: 29662-29668.
13. Frost RA, Nystrom GJ, Lang CH (2004) Epinephrine stimulates IL-6 expression in skeletal muscle and C2C12 myoblasts: role of c-Jun NH2-terminal kinase and histone deacetylase activity. Am J Physiol Endocrinol Metab 286: E809-817. (Pubitemid 38506953)
14. Steensberg A, Toft AD, Schjerling P, Halkjaer-Kristensen J, Pedersen BK (2001) Plasma interleukin-6 during strenuous exercise: role of epinephrine. Am J Physiol Cell Physiol 281: C1001-1004.
15. Bhatnagar S, Panguluri SK, Gupta SK, Dahiya S, Lundy RF, et al. (2010) Tumor necrosis factor-alpha regulates distinct molecular pathways and gene networks in cultured skeletal muscle cells. PLoS One 5: e13262.
16. Spurlock DM, McDaneld TG, McIntyre LM (2006) Changes in skeletal muscle gene expression following clenbuterol administration. BMC Genomics 7: 320.
17. Vanden Berghe W, Plaisance S, Boone E, De Bosscher K, Schmitz ML, et al. (1998) p38 and extracellular signal-regulated kinase mitogen-activated protein kinase pathways are required for nuclear factor-kappaB p65 transactivation mediated by tumor necrosis factor. J Biol Chem 273: 3285-3290. (Pubitemid 28109741)
18. Yaffe D, Saxel O (1977) Serial passaging and differentiation of myogenic cells isolated from dystrophic mouse muscle. Nature 270: 725-727. (Pubitemid 8239246)
19. Blau HM, Chiu CP, Webster C (1983) Cytoplasmic activation of human nuclear genes in stable heterocaryons. Cell 32: 1171-1180. (Pubitemid 13033052)
20. Terrillon S, Bouvier M (2004) Roles of G-protein-coupled receptor dimerization. EMBO Rep 5: 30-34. (Pubitemid 38228524)
21. Bockaert J, Pin JP (1999) Molecular tinkering of G protein-coupled receptors: an evolutionary success. EMBO J 18: 1723-1729. (Pubitemid 29158516)
22. Yoon JH, Song P, Jang JH, Kim DK, Choi S, et al. (2011) Proteomic analysis of tumor necrosis factor-alpha (TNF-alpha)-induced L6 myotube secretome reveals novel TNF-alpha-dependent myokines in diabetic skeletal muscle. J Proteome Res 10: 5315-5325.
23. Pedersen BK, Febbraio MA (2012) Muscles, exercise and obesity: skeletal muscle as a secretory organ. Nat Rev Endocrinol 8: 457-465.
24. Porter JD, Guo W, Merriam AP, Khanna S, Cheng G, et al. (2003) Persistent over-expression of specific CC class chemokines correlates with macrophage and T-cell recruitment in mdx skeletal muscle. Neuromuscul Disord 13: 223-235. (Pubitemid 36279427)
25. Vermeulen L, De Wilde G, Van Damme P, Vanden Berghe W, Haegeman G (2003) Transcriptional activation of the NF-kappaB p65 subunit by mitogen- and stress-activated protein kinase-1 (MSK1). EMBO J 22: 1313-1324. (Pubitemid 36362695)
26. Spooren A, Kooijman R, Lintermans B, Van Craenenbroeck K, Vermeulen L, et al. (2010) Cooperation of NFkappaB and CREB to induce synergistic IL-6 expression in astrocytes. Cell Signal 22: 871-881.
27. Kouzarides T (2007) Chromatin modifications and their function. Cell 128: 693-705.
28. Creyghton MP, Cheng AW, Welstead GG, Kooistra T, Carey BW, et al. (2010) Histone H3K27ac separates active from poised enhancers and predicts developmental state. Proc Natl Acad Sci U S A 107: 21931-21936.
29. Tie F, Banerjee R, Stratton CA, Prasad-Sinha J, Stepanik V, et al. (2009) CBP-mediated acetylation of histone H3 lysine 27 antagonizes Drosophila Polycomb silencing. Development 136: 3131-3141.
30. Wang Z, Zang C, Rosenfeld JA, Schones DE, Barski A, et al. (2008) Combinatorial patterns of histone acetylations and methylations in the human genome. Nat Genet 40: 897-903. (Pubitemid 351913645)
31. Salvador LM, Park Y, Cottom J, Maizels ET, Jones JC, et al. (2001) Follicle-stimulating hormone stimulates protein kinase A-mediated histone H3 phosphorylation and acetylation leading to select gene activation in ovarian granulosa cells. J Biol Chem 276: 40146-40155.
32. Drobic B, Perez-Cadahia B, Yu J, Kung SK, Davie JR (2010) Promoter chromatin remodeling of immediate-early genes is mediated through H3 phosphorylation at either serine 28 or 10 by the MSK1 multi-protein complex. Nucleic Acids Res 38: 3196-3208.
33. Nedachi T, Hatakeyama H, Kono T, Sato M, Kanzaki M (2009) Characterization of contraction-inducible CXC chemokines and their roles in C2C12 myocytes. Am J Physiol Endocrinol Metab 297: E866-878.
34. Zador E, Mendler L, Takacs V, de Bleecker J, Wuytack F (2001) Regenerating soleus and extensor digitorum longus muscles of the rat show elevated levels of TNF-alpha and its receptors, TNFR-60 and TNFR-80. Muscle Nerve 24: 1058-1067. (Pubitemid 32656192)
35. Guttridge DC, Albanese C, Reuther JY, Pestell RG, Baldwin AS Jr (1999) NF-kappaB controls cell growth and differentiation through transcriptional regulation of cyclin D1. Mol Cell Biol 19: 5785-5799. (Pubitemid 29339933)
36. Wertz IE, Dixit VM (2008) Ubiquitin-mediated regulation of TNFR1 signaling. Cytokine Growth Factor Rev 19: 313-324.
37. De Paepe B, Creus KK, De Bleecker JL (2007) Chemokine profile of different inflammatory myopathies reflects humoral versus cytotoxic immune responses. Ann N Y Acad Sci 1109: 441-453. (Pubitemid 47511387)
38. Witherow DS, Garrison TR, Miller WE, Lefkowitz RJ (2004) beta-Arrestin inhibits NF-kappaB activity by means of its interaction with the NF-kappaB inhibitor IkappaBalpha. Proc Natl Acad Sci U S A 101: 8603-8607. (Pubitemid 38745817)
39. Siggers T, Chang AB, Teixeira A, Wong D, Williams KJ, et al. (2012) Principles of dimer-specific gene regulation revealed by a comprehensive characterization of NF-kappaB family DNA binding. Nat Immunol 13: 95-102.
40. Smale ST (2012) Dimer-specific regulatory mechanisms within the NF-kappaB family of transcription factors. Immunol Rev 246: 193-204.
41. Leung TH, Hoffmann A, Baltimore D (2004) One nucleotide in a kappaB site can determine cofactor specificity for NF-kappaB dimers. Cell 118: 453-464. (Pubitemid 39485665)
42. Zhong H, Voll RE, Ghosh S (1998) Phosphorylation of NF-kappa B p65 by PKA stimulates transcriptional activity by promoting a novel bivalent interaction with the coactivator CBP/p300. Mol Cell 1: 661-671. (Pubitemid 128379244)
43. Vermeulen L, De Wilde G, Notebaert S, Vanden Berghe W, Haegeman G (2002) Regulation of the transcriptional activity of the nuclear factor-kappaB p65 subunit. Biochem Pharmacol 64: 963-970. (Pubitemid 35232270)
44. Spooren A, Kolmus K, Vermeulen L, Van Wesemael K, Haegeman G, et al. (2010) Hunting for serine 276-phosphorylated p65. J Biomed Biotechnol 2010: 275892.
45. Kaur M, Holden NS, Wilson SM, Sukkar MB, Chung KF, et al. (2008) Effect of beta2-adrenoceptor agonists and other cAMP-elevating agents on inflammatory gene expression in human ASM cells: a role for protein kinase A. Am J Physiol Lung Cell Mol Physiol 295: L505-514.
46. Baouz S, Giron-Michel J, Azzarone B, Giuliani M, Cagnoni F, et al. (2005) Lung myofibroblasts as targets of salmeterol and fluticasone propionate: inhibition of alpha-SMA and NF-kappaB. Int Immunol 17: 1473-1481. (Pubitemid 41631323)
47. Smale ST (2011) Hierarchies of NF-kappaB target-gene regulation. Nat Immunol 12: 689-694.
48. Monroy MA, Ruhl DD, Xu X, Granner DK, Yaciuk P, et al. (2001) Regulation of cAMP-responsive element-binding protein-mediated transcription by the SNF2/SWI-related protein, SRCAP. J Biol Chem 276: 40721-40726.
49. Shimada M, Nakadai T, Fukuda A, Hisatake K (2010) cAMP-response element-binding protein (CREB) controls MSK1-mediated phosphorylation of histone H3 at the c-fos promoter in vitro. J Biol Chem 285: 9390-9401.
50. Mayr BM, Canettieri G, Montminy MR (2001) Distinct effects of cAMP and mitogenic signals on CREB-binding protein recruitment impart specificity to target gene activation via CREB. Proc Natl Acad Sci U S A 98: 10936-10941. (Pubitemid 32878722)
51. Avni D, Ernst O, Philosoph A, Zor T (2010) Role of CREB in modulation of TNFalpha and IL-10 expression in LPS-stimulated RAW264.7 macrophages. Mol Immunol 47: 1396-1403.
52. Wang Y, Inoue H, Ravnskjaer K, Viste K, Miller N, et al. (2010) Targeted disruption of the CREB coactivator Crtc2 increases insulin sensitivity. Proc Natl Acad Sci U S A 107: 3087-3092.
53. Riccio A, Alvania RS, Lonze BE, Ramanan N, Kim T, et al. (2006) A nitric oxide signaling pathway controls CREB-mediated gene expression in neurons. Mol Cell 21: 283-294. (Pubitemid 43099943)
54. Cha-Molstad H, Keller DM, Yochum GS, Impey S, Goodman RH (2004) Cell-type-specific binding of the transcription factor CREB to the cAMP-response element. Proc Natl Acad Sci U S A 101: 13572-13577. (Pubitemid 39238444)
55. Schreiber SL, Bernstein BE (2002) Signaling network model of chromatin. Cell 111: 771-778. (Pubitemid 36106399)
56. Fischle W, Wang Y, Allis CD (2003) Histone and chromatin cross-talk. Curr Opin Cell Biol 15: 172-183. (Pubitemid 36332192)
57. McManus KJ, Hendzel MJ (2001) CBP, a transcriptional coactivator and acetyltransferase. Biochem Cell Biol 79: 253-266. (Pubitemid 32751918)
58. Holmqvist PH, Mannervik M (2013) Genomic occupancy of the transcriptional co-activators p300 and CBP. Transcription 4: 18-23.
59. Cheung P, Tanner KG, Cheung WL, Sassone-Corsi P, Denu JM, et al. (2000) Synergistic coupling of histone H3 phosphorylation and acetylation in response to epidermal growth factor stimulation. Mol Cell 5: 905-915.
60. Clayton AL, Mahadevan LC (2003) MAP kinase-mediated phosphoacetylation of histone H3 and inducible gene regulation. FEBS Lett 546: 51-58. (Pubitemid 36782281)
61. Lu Q, Hutchins AE, Doyle CM, Lundblad JR, Kwok RP (2003) Acetylation of cAMP-responsive element-binding protein (CREB) by CREB-binding protein enhances CREB-dependent transcription. J Biol Chem 278: 15727-15734. (Pubitemid 36799684)
62. Sundar IK, Chung S, Hwang JW, Lapek JD Jr, Bulger M, et al. (2012) Mitogen- and stress-activated kinase 1 (MSK1) regulates cigarette smoke-induced histone modifications on NF-kappaB-dependent genes. PLoS One 7: e31378.
63. Chen LF, Mu Y, Greene WC (2002) Acetylation of RelA at discrete sites regulates distinct nuclear functions of NF-kappaB. EMBO J 21: 6539-6548. (Pubitemid 35448431)
64. Serrano AL, Baeza-Raja B, Perdiguero E, Jardi M, Munoz-Canoves P (2008) Interleukin-6 is an essential regulator of satellite cell-mediated skeletal muscle hypertrophy. Cell Metab 7: 33-44.
65. Warren GL, O'Farrell L, Summan M, Hulderman T, Mishra D, et al. (2004) Role of CC chemokines in skeletal muscle functional restoration after injury. Am J Physiol Cell Physiol 286: C1031-1036. (Pubitemid 38506918)
66. Corti S, Salani S, Del Bo R, Sironi M, Strazzer S, et al. (2001) Chemotactic factors enhance myogenic cell migration across an endothelial monolayer. Exp Cell Res 268: 36-44. (Pubitemid 32678858)